Effect of Antisense Oligonucleotides against Cholesteryl Ester Transfer Protein on the Development of Atherosclerosis in Cholesterol-fed Rabbits*

Cholesteryl ester transfer protein (CETP) is the enzyme that facilitates the transfer of cholesteryl ester from high density lipoprotein (HDL) to apolipoprotein B (apoB)-containing lipoproteins. However, the exact role of CETP in the development of atherosclerosis has not been determined. In the present study, we examined the effect of the suppression of increased plasma CETP by intravenous injection with antisense oligodeoxynucleotides (ODNs) against CETP targeted to the liver on the development of atherosclerosis in rabbits fed a cholesterol diet. The ODNs against rabbit CETP were coupled to asialoglycoprotein (ASOR) carrier molecules, which serve as an important method to regulate liver gene expression. Twenty-two male Japanese White rabbits were used in the experiment. Eighteen animals were fed a standard rabbit chow supplemented with 0.3% cholesterol throughout the experiment for 16 weeks. At 8 weeks, they were divided into three groups (six animals in each group), among which the plasma total and HDL cholesterol concentrations did not significantly change. The control group received nothing, the sense group were injected with the sense ODNs complex, and the antisense group were injected with the antisense ODNs complex, respectively, for subsequent 8 weeks. ASOR·poly(l-lysine) ODNs complex were injected via the ear veins twice a week. Four animals were fed a standard rabbit diet for 16 weeks. The total cholesterol concentrations and the CETP mass in the animals injected with antisense ODNs were all significantly decreased in 12 and 16 weeks compared with those injected with sense ODNs and the control animals. The HDL cholesterol concentrations measured by the precipitation assay did not significantly change among the groups fed a cholesterol diet, and triglyceride concentrations did not significantly change in the four groups. However, at the end of the study, when the HDL cholesterol concentrations were measured after the isolation by ultracentrifugation and a column chromotography, they were significantly higher in the animals injected with antisense ODNs than in the animals injected with sense ODNs and in the control animals. A reduction of CETP mRNA and an increase of LDL receptor mRNA in the liver were observed in the animals injected with antisense ODNs compared with those injected with sense ODNs and the control animals. Aortic cholesterol contents and the aortic percentage lesion to total surface area were significantly lower in the animals injected with antisense ODNs than in the animals injected with sense ODNs and in the control animals. These findings showed for the first time that suppression of increased plasma CETP by the injection with antisense ODNs against CETP coupled to ASOR carrier molecules targeted to the liver could thus inhibit the atherosclerosis possibly by decreasing the plasma LDL + very low density lipoprotein (VLDL) cholesterol in cholesterol-fed rabbits.

[1]  S. Grundy,et al.  Relation between cholesterol ester transfer protein activities and lipoprotein cholesterol in patients with hypercholesterolemia and combined hyperlipidemia. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[2]  A. Tall,et al.  Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. , 1990, The New England journal of medicine.

[3]  D. Russell,et al.  Deletion in cysteine-rich region of LDL receptor impedes transport to cell surface in WHHL rabbit. , 1986, Science.

[4]  S. Yamashita,et al.  Molecular Defect and Atherogenicity in Cholesteryl Ester Transfer Protein Deficiency , 1994, Annals of the New York Academy of Sciences.

[5]  A. Tall,et al.  Plasma kinetics of cholesteryl ester transfer protein in the rabbit. Effects of dietary cholesterol. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[6]  K. Marotti,et al.  Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein , 1993, Nature.

[7]  E. Rubin,et al.  Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. , 1995, The Journal of clinical investigation.

[8]  S. Yamashita,et al.  Very High Density Lipoproteins Induced by Plasma Cholesteryl Ester Transfer Protein (CETP) Have a Potent Antiatherogenic Function a , 1994, Annals of the New York Academy of Sciences.

[9]  T. Yanaga,et al.  Effect of dietary omega-3 eicosapentaenoic acid supplements on cholesteryl ester transfer from HDL in cholesterol-fed rabbits. , 1997, Biochimica et Biophysica Acta.

[10]  H. Mabuchi,et al.  Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia. , 1985, Atherosclerosis.

[11]  T. Yanaga,et al.  The effects of renin-angiotensin system inhibition on aortic cholesterol content in cholesterol-fed rabbits. , 1996, Atherosclerosis.

[12]  C. Wu,et al.  Enhanced resistance to nuclease degradation of nucleic acids complexed to asialoglycoprotein-polylysine carriers. , 1994, Nucleic acids research.

[13]  A. Tall,et al.  Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins. , 1991, The Journal of clinical investigation.

[14]  C. Wu,et al.  Receptor-mediated gene delivery and expression in vivo. , 1988, The Journal of biological chemistry.

[15]  C. Fielding,et al.  Prebeta-migrating high density lipoprotein: quantitation in normal and hyperlipidemic plasma by solid phase radioimmunoassay following electrophoretic transfer. , 1987, Journal of lipid research.

[16]  Yves,et al.  Monoclonal antibody inhibition of cholesteryl ester transfer protein activity in the rabbit. Effects on lipoprotein composition and high density lipoprotein cholesteryl ester metabolism. , 1989, The Journal of clinical investigation.

[17]  E. Bruckert,et al.  Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[18]  Y. Ozaki,et al.  CETP is a determinant of serum LDL-cholesterol but not HDL-cholesterol in healthy Japanese. , 1996, Atherosclerosis.

[19]  D. Rader,et al.  Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency. , 1995, The Journal of clinical investigation.

[20]  A. Tall,et al.  Purification and characterization of a human plasma cholesteryl ester transfer protein. , 1987, The Journal of biological chemistry.

[21]  R. Lawn,et al.  Cloning and mRNA tissue distribution of rabbit cholesteryl ester transfer protein. , 1988, Journal of lipid research.

[22]  A. Tall,et al.  Atherogenic diet increases cholesteryl ester transfer protein messenger RNA levels in rabbit liver. , 1990, The Journal of clinical investigation.

[23]  A. Tall,et al.  Down-regulation of mRNA for the low density lipoprotein receptor in transgenic mice containing the gene for human cholesteryl ester transfer protein. Mechanism to explain accumulation of lipoprotein B particles. , 1993, The Journal of biological chemistry.

[24]  S. Kihara,et al.  Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[25]  M. Sugano,et al.  Changes in Plasma Lipoprotein Cholesterol Levels by Antisense Oligodeoxynucleotides against Cholesteryl Ester Transfer Protein in Cholesterol-fed Rabbits* , 1996, The Journal of Biological Chemistry.

[26]  C. Wu,et al.  Fate of DNA targeted to the liver by asialoglycoprotein receptor-mediated endocytosis in vivo. Prolonged persistence in cytoplasmic vesicles after partial hepatectomy. , 1993, The Journal of biological chemistry.

[27]  H. Arai,et al.  Purification, microheterogeneity, and stability of human lipid transfer protein. , 1989, The Journal of biological chemistry.

[28]  A. Kuroiwa,et al.  Suppression of Atherosclerosis in Cholesterol‐Fed Rabbits by Diltiazem Injection , 1986, Arteriosclerosis.

[29]  A. Tall,et al.  Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. , 1996, The Journal of clinical investigation.

[30]  B. Föger,et al.  Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol. Studies in normotriglyceridemia and moderate hypertriglyceridemia. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[31]  A. Tall,et al.  Plasma cholesteryl ester transfer protein and high‐density lipoproteins: new insights from molecular genetic studies , 1995, Journal of internal medicine.

[32]  A. Tall,et al.  Cholesteryl ester transfer protein activity enhances plasma cholesteryl ester formation. Studies in CETP transgenic mice and human genetic CETP deficiency. , 1997, Arteriosclerosis, thrombosis, and vascular biology.